Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 301,647 |
|
|||||
| News | (2) | ||||||
| Day High | 849.00 | Low High |
|||||
| Day Low | 838.44 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc | REGN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 7.63 | 0.91% | 847.77 | 13:56:31 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 838.44 | 838.44 | 849.00 | 840.14 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 14,611 | 301,647 | US$ 841.57 | US$ 253,856,761 | - | 668.00 - 853.97 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 13:56:30 | 4 | US$ 847.75 | USD |
Regeneron Pharmaceuticals (REGN) Options Flow Summary
Regeneron Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 92.09B | 108.95M | - | 12.26B | 4.34B | 39.82 | 21.23 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Regeneron Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical REGN Price Data
| Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 804.55 | 850.275 | 802.55 | 835.01 | 467,485 | 43.22 | 5.37% |
| 1 Month | 795.92 | 850.275 | 784.9594 | 811.85 | 476,316 | 51.85 | 6.51% |
| 3 Months | 824.80 | 853.97 | 769.19 | 815.40 | 450,462 | 22.97 | 2.78% |
| 6 Months | 747.84 | 853.97 | 684.805 | 783.99 | 532,126 | 99.93 | 13.36% |
| 1 Year | 730.17 | 853.97 | 668.00 | 770.68 | 563,147 | 117.60 | 16.11% |
| 3 Years | 477.50 | 853.97 | 441.00 | 642.29 | 705,441 | 370.27 | 77.54% |
| 5 Years | 382.17 | 853.97 | 271.37 | 553.65 | 786,760 | 465.60 | 121.83% |
Regeneron Pharmaceuticals Description
| Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer, and bispecific antibodies and antibody cocktails with other collaborators and independently. |
